Jiangxi Institute of Biological Products Inc. (HKG:6915)

Hong Kong · Delayed Price · Currency is HKD

10.74

+0.45 (4.37%)

At close: Oct 7, 2026

Market Cap	3.31B
Revenue (ttm)	252.82M +10.6%
Net Income	83.49M +30.3%
EPS	0.30 +28.9%
Shares Out	308.38M
PE Ratio	35.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,031,500
Open	10.07
Previous Close	10.29
Day's Range	9.99 - 11.00
52-Week Range	3.95 - 21.10
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About HKG:6915

Jiangxi Institute of Biological Products Inc. manufactures and exports biological products including Tetanus Antitoxin and Veterinary Medicine. The company offers Antitoxin Formulations, Active Pharmaceutical Ingredients, Equine Byproducts, essential oils, and plant extracts. It serves businesses in China and international markets. The company was founded in 1969 and is based in Ji'an, China. Jiangxi Institute of Biological Products Inc. is a subsidiary of Shenzhen Qianhai Tianzheng Biotechnology Co., Ltd. [Read more]

Industry Pharmaceutical Preparations

Founded 1969

Employees 349

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6915

Full Company Profile

Financial Performance

In 2025, HKG:6915's revenue was 235.41 million, an increase of 6.64% compared to the previous year's 220.76 million. Earnings were 94.79 million, an increase of 26.16%.

Financial numbers in CNY Financial Statements